Startups Stories
Two years after top KC startup’s sale, Zego (and its new owner) acquired for nearly $1B
The company that acquired Kansas City-based Zego in 2019 — and liked the real estate tech startup’s brand so much it changed its own identity to match — has itself now been purchased by a global “powerhouse” in an all-cash transaction valued at $925 million. Zego — formerly PayLease — announced the acquisition by Global…
T-Mobile Accelerator preps for June 30 demo day; nearly ready to launch new fall cohort
As the Kansas City-based T-Mobile Accelerator readies for its June 30 demo day of immersive technology, the deadline is nearing on applications for a second accelerator program — set to debut this fall with a specific focus on wellness tech. “T-Mobile Accelerator is actively searching for startups developing the next big thing in 5G technologies…
Meet 13 small businesses leading the way on DEI as Chamber’s Equity Award finalists
Some of Kansas City’s youngest companies and startups are among the most committed to achieving DEI goals in the workforce, the Chamber said this week, releasing finalists for its 2021 Small Business Equity Award. The contenders: 13 leading businesses — ranging from lifestyle brands and tech startups to a Kansas City talent agency and an addiction…
Menufy’s online ordering platform helped restaurants survive 2020; now the KC-built company is serving a scale up
The startup course has been cleared for Leawood-plated Menufy as the tech company emerges from the COVID-19 pandemic ready to serve its customers a new identity while doubling down on its decade-old mission to empower restaurateurs. “The pandemic initially complicated things, then accelerated things and kept things complicated. … We don’t really think of ourselves…
Clara Biotech hits $850K in seed funding roundup, preparing to launch first product
An emerging biotech startup in the region is reporting a busy spring with a significant seed round already raised and key steps under way to launch its product: a solution that removes manufacturing roadblocks for breakthrough drugs. “We’re in an exciting and growing space and currently have low regulatory hurdles in the research stage,” said…
